767 related articles for article (PubMed ID: 30489194)
1. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
[TBL] [Abstract][Full Text] [Related]
2. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA NNT-AS1 promotes gastric cancer proliferation and invasion by regulating microRNA-363 expression.
Wang X; Ren M; Li Y; Hu J; Lu G; Ma W; Guo D; Lu X; He S
J Cell Biochem; 2019 Apr; 120(4):5704-5712. PubMed ID: 30324628
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
Gu Y; Zhu Z; Pei H; Xu D; Jiang Y; Zhang L; Xiao L
Aging (Albany NY); 2020 Feb; 12(3):2333-2346. PubMed ID: 32019904
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis.
Cui H; Zhao J
J Cell Biochem; 2020 Mar; 121(3):2284-2293. PubMed ID: 31680323
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
Jia F; Zhang Z; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
Yang C; Wu K; Wang S; Wei G
J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
[TBL] [Abstract][Full Text] [Related]
9. LncRNA FTX inhibition restrains osteosarcoma proliferation and migration via modulating miR-320a/TXNRD1.
Huang S; Zhu X; Ke Y; Xiao D; Liang C; Chen J; Chang Y
Cancer Biol Ther; 2020 Apr; 21(4):379-387. PubMed ID: 31920141
[TBL] [Abstract][Full Text] [Related]
10. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
Zhou Y; Feng D; Gu X; Gao A; Liu Y
Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
[TBL] [Abstract][Full Text] [Related]
11. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9).
Zhang H; Liu S; Tang L; Ge J; Lu X
Bioengineered; 2021 Dec; 12(1):162-171. PubMed ID: 33356805
[TBL] [Abstract][Full Text] [Related]
13. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
14. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.
Dai JH; Huang WZ; Li C; Deng J; Lin SJ; Luo J
Cell Cycle; 2019 Oct; 18(20):2727-2741. PubMed ID: 31432728
[No Abstract] [Full Text] [Related]
15. LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis.
Huang JW; Luo XY; Li ZH; Lang BP
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):238-248. PubMed ID: 31957837
[TBL] [Abstract][Full Text] [Related]
16. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
Tan H; Zhao L
J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA
Li S; Liu F; Pei Y; Wang W; Zheng K; Zhang X
Aging (Albany NY); 2019 Sep; 11(18):7678-7693. PubMed ID: 31525734
[TBL] [Abstract][Full Text] [Related]
18. LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis.
Zhu H; Zhai B; He C; Li Z; Gao H; Niu Z; Jiang X; Lu J; Sun X
Cell Death Dis; 2020 Aug; 11(8):637. PubMed ID: 32801339
[TBL] [Abstract][Full Text] [Related]
19. LncRNA ROR1-AS1 accelerates osteosarcoma invasion and proliferation through modulating miR-504.
Wu X; Yan L; Liu Y; Shang L
Aging (Albany NY); 2020 Dec; 13(1):219-227. PubMed ID: 33401251
[TBL] [Abstract][Full Text] [Related]
20. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
